May 26, 2019nih

PRA, Safety, Biotage

News Briefs

May 01, 2007

The U.S. Senate began discussion of a bill to beef up spending on drug safety. UPI reports that a new $30 million program would be used for surveillance of drug safety issues. That would be part of a new total of $300 million in user fees charged to the industry for reviewing applications. A patient recruitment provider D. Anderson & Company (DAC) has entered a partnership with Metroplex Clinical Research Center (MCRC) to exchange ideas and enhance best practices in patient recruitment for the clinical trials industry. DAC is a patient recruitment and retention leader in the clinical trials industry with more than 15 years of experience spanning more than 30 countries. PRA International, a clinical research organization, announced in its latest press release that Kent R. Thoelke, Senior Vice President, Therapeutic Expertise, Scientific & Medical Affairs, will present a one-hour audio conference on conducting feasibility prior to global clinical research…more...

Using The 'Mommy' Test

Trial Stopped Prematurely, Says Nissen

January 10, 2007

A leading cardiologist at the Cleveland Clinic, Steve Nissen, is charging that the NIH had a panic attack and should have allowed the ADAPT trial to continue. The ADAPT trial, for…more...

No articles available

No articles available

© 2019 ClinPage. All Rights Reserved.